Tallantyre, Emma ORCID: https://orcid.org/0000-0002-3760-6634, Castle, Daniel, Karamura, Paul, Brice, Thomas, Joseph, Fady, Harding, Katharine and Robertson, Neil ORCID: https://orcid.org/0000-0002-5409-4909 2020. Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort. Multiple Sclerosis and Related Disorders 42 , 102056. 10.1016/j.msard.2020.102056 |
Castle, Daniel and Robertson, Neil P. ORCID: https://orcid.org/0000-0002-5409-4909 2019. Treatment of progressive multifocal leukoencephalopathy. Journal of Neurology 266 (10) , pp. 2587-2589. 10.1007/s00415-019-09501-y |
Castle, Dan and Robertson, Neil P. ORCID: https://orcid.org/0000-0002-5409-4909 2019. Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neurology 266 (9) , pp. 2338-2340. 10.1007/s00415-019-09485-9 |
Castle, Daniel, Wynford-Thomas, Ray, Loveless, Sam ORCID: https://orcid.org/0000-0002-5124-4115, Bentley, Emily, Howell, Owain W and Tallantyre, Emma C ORCID: https://orcid.org/0000-0002-3760-6634 2019. Using biomarkers to predict clinical outcomes in multiple sclerosis. Practical Neurology 19 (4) , pp. 342-349. 10.1136/practneurol-2018-002000 |